Leading the Way in Life Science Technologies

GEN Exclusives

More »

Columns

More »

For full access to this article login to GEN Select now.

March 15, 2015 (Vol. 35, No. 6)

Blood Can Replace Tissue Biopsies

Cynvenio Biosystems’ Diagnostic Platform Analyzes cDNA, Captures Cancer’s Dynamism

  • Cynvenio Biosystems, with its LiquidBiopsy ® rare cell isolation and genomic analysis platform, is at the forefront of cancer diagnostics. Rather than rely on tissue biopsies or counting circulating tumor cells in the blood, this technology extracts and sequences those cells’ DNA. That, in turn, makes possible real-time analysis ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.